nonglial tumors
Showing 1 - 25 of >10,000
Gastrointestinal Cancer Screening Based on Patient-related Risk
Not yet recruiting
- Malignant Tumor of Digestive Tract
- Risk Factors
-
Xi'an, Shaanxi, ChinaXijing of Digestive Diseases
Nov 1, 2023
Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)
Not yet recruiting
- Her2-positive/Low-expression Urinary and Digestive Tract Tumors
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023
Solid Tumor, Adult Trial in Beijing (Vaccine)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 3, 2023
Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA
Not yet recruiting
- Adrenal Cortical Carcinoma
- +3 more
- individualized mRNA neoantigen vaccine (mRNA-0523-L001)
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023
Germ Cell Tumor and Testicular Tumor DNA Registry
Recruiting
- Germ Cell Tumor
- Testicular Tumor
- Questionnaires
- sample of blood or saliva
-
Basking Ridge, New Jersey
- +7 more
Jan 31, 2023
Neutrophils to Lymphocytes Ratio in Predicting Response to BCG
Completed
- Urinary Bladder Cancer
- +4 more
- Neutrophil to lymphocyte ratio
-
Cairo, EgyptAin Shams university
Jul 15, 2023
Doppler Ultrasound and CT Versus Laparoscopy in Assessment of
Recruiting
- Ovarian Cancer
- Laparoscopy
-
Mansoura, Dakahlia, EgyptMansoura University Hospital
Oct 25, 2023
Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- (no location specified)
Jun 21, 2023
NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT
Recruiting
- Advanced Solid Tumors or Lymphomas
-
Changsha, Hunan, ChinaHunan Provincal Tumor Hospital
Oct 5, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor
Not yet recruiting
- HER2-expressing Advanced Solid Tumors
- SHR-A1811 combined with Pyrotinib.
- SHR-A1811 combined with other antitumor therapies
- (no location specified)
Aug 28, 2023
Cardiac Tumor and Risk Stratification of Subsequent Adverse
Not yet recruiting
- Cardiac Tumor
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiantong University
Oct 19, 2023
Advanced Solid Tumor Trial in China (7MW3711 for injection)
Not yet recruiting
- Advanced Solid Tumor
- 7MW3711 for injection
-
Changsha, Hunan, China
- +3 more
Aug 18, 2023
Advanced Solid Tumor Trial (7MW3711 for injection)
Not yet recruiting
- Advanced Solid Tumor
- 7MW3711 for injection
- (no location specified)
Aug 18, 2023
Brain Slice Explants to Predict Drug Response in Brain Tumors
Not yet recruiting
- Central Nervous System Tumor
- Biospecimen collection
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 28, 2023
Imaging Features in Invasiveness and Prognosis of Pituitary
Recruiting
- Pituitary Adenoma
- Neuroendocrine Tumors
- diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
-
Guangzhou, Guangdong, Chinaendocrinology department of the first affiliated hospital of Sun
Aug 24, 2023
Advanced Solid Tumors Trial in Wuhan (HV-101)
Recruiting
- Advanced Solid Tumors
- HV-101
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
May 11, 2023
MSI-H Colorectal Cancer Trial (colorectal resection)
Completed
- MSI-H Colorectal Cancer
- colorectal resection
- (no location specified)
May 22, 2023
Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,
Not yet recruiting
- Lymphocytes
- Tumor-Infiltrating
- Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
-
Saint Petersburg, Florida
- +1 more
Sep 15, 2023
Advanced Solid Tumor Trial in Chengdu (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)
Not yet recruiting
- Advanced Solid Tumor
- Dual-targeting CLDN18.2 and PD-L1 CAR-T cells
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 9, 2023
Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)
Recruiting
- Advanced or Metastatic Solid Tumor
- KRAS G12C Mutation
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Nov 2, 2023
Spinal Cord Tumors Trial in Shenyang (Magnetic Resonance Elastography, Assessment and Recording)
Recruiting
- Spinal Cord Tumors
- Magnetic Resonance Elastography
- Assessment and Recording
-
Shenyang, Liaoning, ChinaShengjing Hospital
Jul 25, 2023
Cryoablation for Advanced and Refractory Desmoid Tumors
Recruiting
- Desmoid Tumors
-
Strasbourg, FranceService d'Imagerie Interventionnelle - CHU de Strasbourg - Franc
Oct 30, 2023
Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC) Trial in
Recruiting
- Esophageal Squamous Cell Carcinoma (ESCC)
- +2 more
- pembrolizumab
- +7 more
-
Long Beach, California
- +158 more
Jan 19, 2023